Equities

BPH Global Ltd

BPH Global Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.001
  • Today's Change0.00 / 0.00%
  • Shares traded2.95k
  • 1 Year change-75.00%
  • Beta1.9512
Data delayed at least 20 minutes, as of Apr 30 2024 01:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BPH Global Ltd is a plant-focused biotechnology company. The Company is focused on producing foods and products that deliver Traditional Chinese Medicine-based health outcomes. It focuses on the research and development, production and commercialization of plant-based products, including seaweed and sea plants to produce sustainable plant-based protein foods and nutraceutical and pharmaceutical ingredients (including cannabidiol (CBD) extracted from Hemp) for utilization in the food, nutrition, healthcare, cosmetics, and personal care industries. Its principal business focus is on Singapore, Australia, Southeast Asia, and Chinese markets. The Company produces its products through various plants, which include Caulerpa lentillifera, Dendrobium officinale, Resina and Cannabis sativa. It is also into the sales and distribution of bird's nest products in China. Its subsidiaries include Stemcell United Pte Ltd, Stemcell Essential Pte Ltd, and SCU Southeast Asia Sdn Bhd, SCU (HK) Ltd.

  • Revenue in AUD (TTM)0.00
  • Net income in AUD-2.56m
  • Incorporated1984
  • Employees31.00
  • Location
    BPH Global LtdLevel 5, 126 Phillip StreetSYDNEY 2000AustraliaAUS
  • Phone+61 28072-1400
  • Fax+61 28072-1400
  • Websitehttps://scu.com.sg/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BP8:ASX since
announced
Transaction
value
Foshan Gedishi Biotechnology Co LtdDeal completed20 Sep 202320 Sep 2023Deal completed--123.00k
Data delayed at least 20 minutes, as of Apr 30 2024 01:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nutritional Growth Solutions Ltd4.61m-4.47m1.26m--------0.2724-0.0246-0.02460.0239-0.00111.512.1961.53---145.93---303.09--28.2242.47-96.95-152.300.1888--1.96--1.2641.6131.91------
Wellfully Ltd1.31m-1.34m1.48m36.00------1.13-0.003-0.0030.0034-0.00340.3770.31661.57---38.36-175.88---441.8448.61---101.74-266.080.2159-------42.78-5.8712.98--21.75--
Hexima Ltd193.85k-753.18k1.84m----0.7221--9.48-0.0045-0.00450.00120.01520.0558--0.2705---21.67-72.85-26.54-193.37-----388.54-213.09----0.00--271.52-19.4380.85------
Tryptamine Therapeutics Ltd1.21m-4.32m1.93m----1.78--1.60-0.0162-0.01620.00370.00620.2368-------84.69-66.34-120.26-79.70-----357.70-228.11---21.620.00---18.97138.7329.29--68.45--
BPH Global Ltd0.00-2.56m1.95m31.00---------0.002-0.00250.00-0.00020.000.00-----177.78-68.17-784.87-128.99--15.29---131.890.5587-4.92-----99.93-74.0819.71--1.34--
Melodiol Global Health Ltd19.60m-35.52m2.02m--------0.1031-0.2548-0.37620.1578-0.01720.68744.3510.62---124.57-102.92-387.77-152.3215.38---181.22-348.920.1594-6.711.73--210.1394.60-62.47---46.82--
Holista Colltech Limited5.95m-4.81m2.79m3.00------0.4686-0.0172-0.01720.0213-0.00711.352.494.70---111.49-42.59-347.69-63.5856.6656.37-82.68-39.270.2845-------27.82-5.65-230.77---37.12--
Hydration Pharmaceuticals Co Ltd15.51m-12.52m3.45m--------0.2222-0.0642-0.06420.0795-0.00211.181.616.60---94.86-79.98-143.75-111.5753.7048.73-80.69-99.531.37-21.481.10--10.3419.2723.61------
Bod Science Ltd3.32m-7.95m4.26m--------1.28-0.0557-0.05570.0235-0.00460.75332.428.05---180.40-94.62-465.66-145.7769.2347.08-239.47-129.480.8319--3.71---34.7023.20-47.10--8.23--
Data as of Apr 30 2024. Currency figures normalised to BPH Global Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.